HighMark Wealth Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-51
Closed -$1.15K 604
2024
Q2
$1.15K Hold
51
﹤0.01% 503
2024
Q1
$1.21K Hold
51
﹤0.01% 497
2023
Q4
$1.22K Hold
51
﹤0.01% 495
2023
Q3
$1.11K Hold
51
﹤0.01% 497
2023
Q2
$975 Hold
51
﹤0.01% 505
2023
Q1
$990 Hold
51
﹤0.01% 541
2022
Q4
$818 Hold
51
﹤0.01% 486
2022
Q3
$1K Hold
51
﹤0.01% 472
2022
Q2
$1K Hold
51
﹤0.01% 472
2022
Q1
$1K Hold
51
﹤0.01% 480
2021
Q4
$1K Hold
51
﹤0.01% 470
2021
Q3
$1K Hold
51
﹤0.01% 478
2021
Q2
$1K Hold
51
﹤0.01% 484
2021
Q1
$1K Hold
51
﹤0.01% 456
2020
Q4
$1K Hold
51
﹤0.01% 425
2020
Q3
$1K Hold
51
﹤0.01% 417
2020
Q2
$1K Hold
51
﹤0.01% 407
2020
Q1
$0 Buy
+51
New +$933 ﹤0.01% 370

Other funds holding EXEL

HighMark Wealth Management's EXEL Position: Q3 2024 in Review

HighMark Wealth Management sold out of Exelixis (EXEL) in Q3 2024, closing a stake of 51 shares — an estimated $1.15K sold.

HighMark Wealth Management first reported a position in EXEL in Q1 2020 and held it in 18 quarters. The position peaked at $1.22K in Q4 2023. 452 funds tracked by Wall St. Rank hold EXEL as of Q3 2024.

  • HighMark Wealth Management reported no remaining Exelixis position as of Q3 2024 after selling out during the quarter.
  • HighMark Wealth Management sold 51 Exelixis shares in Q3 2024, an estimated $1.15K.
  • HighMark Wealth Management first reported a position in Exelixis in Q1 2020 and held it in 18 quarters.
  • HighMark Wealth Management's Exelixis position peaked at $1.22K in Q4 2023.
  • 452 funds tracked by Wall St. Rank held Exelixis as of Q3 2024.

Based on HighMark Wealth Management's 13F filing for Q3 2024, filed 17 Oct 2024.